NCT00890981View on ClinicalTrials.gov

A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab

PHASE3CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

August 31, 2010

Conditions
Low Bone MassLow Bone Mineral DensityOsteoporosisPostmenopausal Osteoporosis
Interventions
PROCEDURE

high-resolution peripheral quantitative computed tomography (HR-pQCT)

Bone densitometry and microarchitecture assessments of the distal radius and the distal tibia by HR-pQCT on Day 1.

PROCEDURE

Dual energy X-ray absorptiometry (DXA)

Bone densitometry assessments of the forearm by DXA on day 1.

BIOLOGICAL

Denosumab

Denosumab 60 mg subcutaneously every 6 months in the previous study

DRUG

Placebo

Placebo to denosumab subcutaneously every 6 months in the previous study

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00890981 - A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab | Biotech Hunter | Biotech Hunter